avera.io

What It Is

Avera is a graph-native platform and delivery model for regulated medical device development. Its goal is to put requirements, BOM, risk, V&V, manufacturing, and post-market feedback into a single graph, replacing the fragmented stack of traditional ALM, PLM, and QMS tools. The company is registered in Bern, Switzerland, with primary hosting on AWS eu-central-1, and emphasizes compliance contexts such as GDPR, eIDAS, ZertES, and medical device regulations.

Core Capabilities

Its core value is not as a standalone document tool, but in treating traceability relationships as a database-native capability. LiveDocs can generate DHF, DMR, 510(k), eSTAR, and MDR technical documentation from graph data; impact analysis can trace related outputs, risk controls, and verification protocols after design inputs change. The AI layer uses Claude via MCP to draft risk analyses, V&V protocols, and submission sections, but all recommendations must be manually approved before entering system records. The platform also provides immutable audit trails, electronic signatures, a 21 CFR Part 11 statement, branch/variant management, Explorer mount, and closed-loop tracking from post-market complaints back into design iterations.

Pricing and Delivery

Avera uses a “Roadmap + Capability + Engine” model: it starts with a fixed-fee 4–8 week regulatory and product roadmap, followed by team enablement and certification, and only begins platform billing once the team is ready. The materials mention that startups can be billed per seat as their team grows, but no public unit pricing, package tiers, or payment methods are provided.

Pros and Cons

Its strengths are a focused use case and mature compliance language, directly addressing pain points for medical device teams such as rebuilding traceability matrices before audits, fragmented tools, and delayed technical documentation. Its AI guardrails are also relatively clear, including no training on customer data, node-level opt-in, and API call auditing. The weaknesses are that SOC 2 Type II and ISO 27001 are still in preparation, while customer cases, pricing, permission models, and API documentation are limited. The company also shows early-stage characteristics, so buyers should pay particular attention to validating maturity and implementation capability.

Who It’s For and China Access

Avera is best suited for Class II or more heavily regulated medical device startups, companies already using combinations of Jama/Polarion/Windchill/Arena/QMS, as well as engineering service providers and investment firms. The available materials do not state its accessibility from China. Given that it is hosted in Europe and its AI depends on Anthropic/Claude, network reachability, cross-border data transfer, contract payments, and local alternatives should be evaluated separately. Alternatives include Jama, Polarion, Windchill, Arena, Teamcenter, Greenlight Guru, MasterControl, Veeva QMS, and others.